相关实验视频

Updated: Jan 16, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

在癌症免疫治疗中使用金属纳米药物

Shixuan Li¹, Xiaohu Wang¹, Huiyun Han¹

¹Department of Pharmaceutics, Jiangsu Key Laboratory of Drug Design and Optimization, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.

Acta pharmaceutica Sinica. B

|October 6, 2025

概括

金属免疫疗法使用金属元素通过调节免疫系统来增强癌症治疗. 纳米技术的整合优化了基于金属的药物,以提高抗瘤免疫力,尽管临床使用仍然存在挑战.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
材料科学材料科学材料科学

背景情况:

免疫疗法是癌症的关键治疗方法,但其疗效受到瘤微环境 (TME) 耐药性的限制.
金属元素在调节抗瘤免疫力方面发挥着至关重要的作用.
金属免疫疗法,结合金属和免疫疗法,提供了一个有希望的策略.

研究的目的:

审查金属材料如何调节抗瘤免疫的生物活动.
总结金属免疫疗法的智能药物输送系统的进展.
讨论纳米药在金属免疫治疗中的临床应用和挑战.

主要方法:

关于金属元素在癌症免疫力中的作用的文献综述.
分析基于纳米技术的药物输送系统用于金属免疫疗法.
审查当前的临床试验和未来的挑战.

主要成果:

金属材料可以被设计为调节免疫细胞和编排抗瘤反应.
智能药物输送系统提高了基于金属的免疫治疗药物的疗效.
早期临床试验显示出潜力,但生产可扩展性和生物安全性是关键问题.

结论:

金属免疫疗法,特别是纳米药物,显示出癌症治疗的巨大潜力.
优化金属离子输送和解决安全问题对于临床翻译至关重要.
需要进一步的研究来克服大规模生产和长期生物安全方面的挑战.

关键词:

生物安全生物安全癌症免疫疗法癌症免疫疗法临床应用临床应用药物输送系统是药物输送系统.免疫反应的免疫反应.金属纳米医药 - 金属纳米医药纳米技术纳米技术瘤微环境是一个微环境.

更多相关视频

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...